Diagnostic and pathogenic significance of glutamate receptor autoantibodies

Research output: Contribution to journalArticlepeer-review

25 Scopus citations


Autoantibodies against glutamate receptors, first reported in Rasmussen encephalitis, have been observed in other focal epilepsies, central nervous system ischemic infarcts, transient ischemic attacks, sporadic olivopontocerebellar atrophy, systemic lupus erythematosus, and paraneoplastic encephalopathies. The detection of glutamate receptor autoantibodies is not useful in the evaluation of Rasmussen encephalitis but may be a biomarker for brain ischemia, and it is helpful in diagnosing certain paraneoplastic encephalopathies. Passive transfer of glutamate receptor autoantibodies from patients with systemic lupus erythematosus or paraneoplastic encephalopathy suggests that glutamate receptor autoantibodies can actively contribute to neurologic dysfunction.

Original languageEnglish (US)
Pages (from-to)589-592
Number of pages4
JournalArchives of Neurology
Issue number5
StatePublished - May 2008

ASJC Scopus subject areas

  • Neuroscience(all)


Dive into the research topics of 'Diagnostic and pathogenic significance of glutamate receptor autoantibodies'. Together they form a unique fingerprint.

Cite this